Boots unveils profits slide

High street pharmacist Boots today reported a 17% fall in annual pre-tax profits as restructuring costs, including exiting loss-making businesses, took their toll.

The company has been reshaping itself to concentrate on core businesses Boots the Chemist and Healthcare International, the division behind consumer brands including Nurofen, Strepsils and Clearasil.